10/2/18: RTI will acquire all outstanding equity interest of Paradigm Spine in a cash and stock transaction valued at up to $300 million, consisting of $150 million at closing plus potential future milestone payments. RTI believes this transaction underscores its significant progress executing against its strategic transformation to reduce complexity, drive operational excellence and accelerate growth.
RTI Surgical Reaches Global Milestone of Providing 8 Million Biologic Implants with Zero Confirmed Incidence of Implant-Associated Infection
4/4/18: RTI celebrates 20-year anniversary of providing safe, high-quality surgical implants
3/28/18: Study finds SImmetry significantly reduces range of motion and provides an environment for fusion in the sacroiliac joint, a central goal for treating long-term SI joint dysfunction
RTI Surgical® Introduces TETRAfuse® 3D Technology Becoming First to Offer 3D Printed Interbody Polymer Optimized to Participate in Fusion
TETRAfuse 3D Technology is the first 3D printed polymer implant material that has demonstrated trabecular bone ingrowth while maintaining radiolucency and bone-like mechanical properties.